CSL is a global pharma company active in the development of vaccines and plasma proteins with a prime focus on influenza vaccine - partnering, collaborative R&D and licensing activity of CSL is reviewed here.
CSL announced over 30 partnering / licensing deals since 2005, with 12 deals in 2012 alone.
Abstracted from: Partnering Deals and Alliances with CSL
The number of partnering, collaborative R&D and licensing deals announced varied year on year with a significant increase in 2008 and continued at a fairly steady pace since then.
The following figure shows the level of CSL partnering deal announcements since 2005.
Figure 1: CSL partnering deals 2005-2013
Source: Current Agreements, 2013
Analysis of the partnering deals shows an emphasis on partnerships in infectives and hematology diseases. This reflects the strong focus area of CSL in it's R&D efforts in influenza vaccines.
The following table provides an overview of the partnering deals announced by CSL based on therapy area disclosed. Our report provides a more detailed insight into the precise therapeutic target of each deal. See: Partnering Deals and Alliances with CSL
Figure 2: CSL partnering deals by therapy area 2005-2013
Source: Current Agreements, 2013
Further analysis of these deals shows that CSL has a preference for licensing and supply deals almost similar to many other top pharmaceutical or big biotech companies. Such partnering deals provide the right for CSL to exploit the licensors technology in return for payment of upfront, development and sales, and royalty payments.
The following table provides an overview of the partnering deals announced by CSL based on deal type disclosed.
Figure 3: CSL partnering deals by deal type 2005-2013
When looking at the stage of development at deal signing, the most popular stages of signing are at discovery and marketed with 9 deal announcements each. These crucial stages of partnering reflect on the company’s successful R&D and marketing strategy.
The following table provides an overview of the partnering deals announced by CSL based on stage of development at signature.
Figure 4: CSL partnering by stage of development 2005-2013
Source: Current Agreements, 2013
CSL has signed over 30 partnering, collaborative R&D and licensing deals since 2005. The following provides a summary of the top deals by headline value.
Figure 5: Top CSL partnering deals by headline value 2005-2013
Our report provides more detailed insight into the details of each deal. See: Partnering Deals and Alliances with CSL
CSL partnering at Current Agreements
View all partnering deals for CSL: 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005
Full details on each deal can be found at CurrentAgreements (subscription required)
See also
Available reports from Current Partnering
Report: Partnering Deals and Alliances with CSL
Report: Top 50 Big Pharma Partnering and M&A Deal Trends
More
Available resources for deal coverage for CSL
Subscribe: Current Agreements life sciences partnering, M&A and financing deals database – find out more
Read: more on CSL company profile, recent partnering, M&A and financing news and articles
Related
Report: Practical Guide to Finding Partners
View: Current Partnering’s Partnering Scorecard – view top life science partnering deals by value
View: Current Partnering’s M&A Scorecard – view top life science M&A deals by value
View: Current Partnering’s Deal Metrics – the latest deal trend infographics for life science deal making
View: Current Partnering’s Big Pharma Deal Making Scorecard – latest trends in big pharma deal making activity
Signup: Current Partnering Dealmakers Update – weekly newsletter providing the latest life science industry deal news, deal making trends, partnering events – sign up now
Signup: Current Agreements Deals Review – monthly newsletter - reviewing the previous month’s life science deal making – partnering, M&A and financing – sign up now
View: Top 50 pharma – overview of top 50 pharmaceutical companies by revenue – partnering activity, deal news, partnering dealtalk
View: Top 50 biotech – overview of top 50 biotechnology companies by revenue – partnering activity, deal news, partnering dealtalk
Follow us on: LinkedIn Current Partnering | LinkedIn Business Development Network | @Currentpartner on Twitter
